The Modern Role of Radiation Therapy in Classic Hodgkin Lymphoma.
기술보고
1/5 보강
Radiation therapy (RT) has played a central role in the management of classic Hodgkin lymphoma (cHL) for over a century and remains an integral component of modern, risk-adapted treatment strategies.
APA
Dreyfuss AD, Yahalom J (2026). The Modern Role of Radiation Therapy in Classic Hodgkin Lymphoma.. Hematology/oncology clinics of North America, 40(2), 257-274. https://doi.org/10.1016/j.hoc.2026.01.001
MLA
Dreyfuss AD, et al.. "The Modern Role of Radiation Therapy in Classic Hodgkin Lymphoma.." Hematology/oncology clinics of North America, vol. 40, no. 2, 2026, pp. 257-274.
PMID
41679983 ↗
Abstract 한글 요약
Radiation therapy (RT) has played a central role in the management of classic Hodgkin lymphoma (cHL) for over a century and remains an integral component of modern, risk-adapted treatment strategies. Advances in systemic therapy, molecular imaging, and radiation technique have enabled substantial reductions in treatment fields and dose while maintaining excellent disease control. This article reviews the evolution of RT in cHL, contemporary evidence guiding its use in early-stage and in advanced-stage disease, and its evolving role in relapsed and refractory settings, including peritransplant and emerging transplant-alternative approaches.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Association of patient health education with the postoperative health related quality of life in low- intermediate recurrence risk differentiated thyroid cancer patients.
- Early local immune activation following intra-operative radiotherapy in human breast tissue.